dihydro-beta-erythroidine has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, M; Takeda, K; Yamaguchi, Y | 1 |
| Arthur, D; Levin, ED | 1 |
2 other study(ies) available for dihydro-beta-erythroidine and Cognition Disorders
| Article | Year |
|---|---|
Combination effects of ZSET1446/ST101 with memantine on cognitive function and extracellular acetylcholine in the hippocampus.
Topics: Acetylcholine; Administration, Oral; Animals; Cognition; Cognition Disorders; Dihydro-beta-Erythroidine; Drug Synergism; Drug Therapy, Combination; Hippocampus; Indans; Male; Mecamylamine; Memantine; Memory Disorders; Mice; Mice, Inbred ICR; Nicotinic Antagonists; Rats; Rats, Wistar; Spiro Compounds | 2013 |
Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Dihydro-beta-Erythroidine; Female; Hippocampus; Memory; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors | 2002 |